TEST:

oncoReveal™ Solid Tumor v2 Panel

The Pillar oRSTv2 NGeniuS application is capable of producing consistent high-quality libraries with minimal hands-on time and manual intervention. This system and our application will now provide clinical laboratories with low to moderate sample volume an opportunity to automate library preparation and expedite the delivery of NGS results.

We successfully assessed the performance of the QIAxcel Connect system for NGS library prep QC analysis. In addition, employing this system significantly diminished the utility of the library quantification from testing each individual library to testing 1 pooled library for each panel, and subsequently reduced reagent cost, labor cost, workflow complexity, and potential human errors.

"Pillar Biosciences said Wednesday that more of its OncoReveal next-generation sequencing panels will be offered by Illumina in an expansion of the companies’ existing partnership...The deal includes the OncoReveal Essential MPN, Myeloid, Multi-Cancer with CNV and Fusion panel, and BRCA1 and BRCA2 plus CNV panel, which will be available as part of validated workflows on the MiSeq i100 sequencer launched last week."

"Beckman Coulter Life Sciences...announces a collaboration agreement with Pillar Biosciences, which develops and distributes IVD & RUO NGS testing solutions based on their proprietary SLIMamp® technology to help localize patient testing and optimize the selection of precision therapies for cancer patients...The application development partnership is initially focused on five commercially-available, solid tumor liquid biopsy and hematology panels from Pillar Biosciences..."